Southern Star Research
Kellie Lantry is a highly experienced Quality Assurance professional with a background in Biology/Biological Sciences. Kellie has held various roles in companies such as Southern Star Research, Novotech, Calimmune, Inc., and Johnson & Johnson Research, specializing in ensuring quality standards are met. Prior to their career in industry, Kellie also worked as a Scientific Officer and GLP Inspector at the National Association of Testing Authorities, Australia.
This person is not in any offices
Southern Star Research
Sydney-based CRO Southern Star Research can access the financial, operational and regulatory advantages of conducting clinical trials in Australia. This local knowledge, as well as our full-service offering, enables our biotechnology, pharmaceutical and medical device customers to benefit from the Australian environment. We have expertise in a broad range of indications, and a Clinical Team who have an average of 17 years direct clinical research experience. Furthermore, all of our work is underpinned by a passion for cutting edge science, a keen interest in early stage clinical development and a willingness to provide every client with exceptional customer service. With a track record of success in clinical trials spanning Phase I to IV, Southern Star Research has both the capability and the drive to support your R&D objectives in Australia and Asia-Pacific.